These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37808702)

  • 41. The biology and the genetics of Hurthle cell tumors of the thyroid.
    Máximo V; Lima J; Prazeres H; Soares P; Sobrinho-Simões M
    Endocr Relat Cancer; 2012 Aug; 19(4):R131-47. PubMed ID: 22514109
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of LDH-A as a therapeutic target for cancer cell killing via (i) p53/NAD(H)-dependent and (ii) p53-independent pathways.
    Allison SJ; Knight JR; Granchi C; Rani R; Minutolo F; Milner J; Phillips RM
    Oncogenesis; 2014 May; 3(5):e102. PubMed ID: 24819061
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pyruvate dehydrogenase complex and lactate dehydrogenase are targets for therapy of acute liver failure.
    Ferriero R; Nusco E; De Cegli R; Carissimo A; Manco G; Brunetti-Pierri N
    J Hepatol; 2018 Aug; 69(2):325-335. PubMed ID: 29580866
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thyroid Cancer-Associated Mitochondrial DNA Mutation G3842A Promotes Tumorigenicity via ROS-Mediated ERK1/2 Activation.
    Chen S; Bao X; Chen H; Jia M; Li W; Zhang L; Fan R; Fang H; Jin L
    Oxid Med Cell Longev; 2022; 2022():9982449. PubMed ID: 35464760
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blockade of Lactate Dehydrogenase-A (LDH-A) Improves Efficacy of Anti-Programmed Cell Death-1 (PD-1) Therapy in Melanoma.
    Daneshmandi S; Wegiel B; Seth P
    Cancers (Basel); 2019 Mar; 11(4):. PubMed ID: 30934955
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Age related rise in lactate and its correlation with lactate dehydrogenase (LDH) status in post-mitochondrial fractions isolated from different regions of brain in mice.
    Datta S; Chakrabarti N
    Neurochem Int; 2018 Sep; 118():23-33. PubMed ID: 29678731
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lactate dehydrogenase inhibitors sensitize lymphoma cells to cisplatin without enhancing the drug effects on immortalized normal lymphocytes.
    Manerba M; Di Ianni L; Fiume L; Roberti M; Recanatini M; Di Stefano G
    Eur J Pharm Sci; 2015 Jul; 74():95-102. PubMed ID: 25930121
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolic Response to the Mitochondrial Toxin 1-Methyl-4-phenylpyridinium (MPP+) in LDH-A/B Double-knockout LS174T Colon Cancer Cells.
    Mack N; Mazzio E; Badisa R; Soliman KFA
    Cancer Genomics Proteomics; 2021; 18(3 Suppl):385-405. PubMed ID: 33994363
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of a rational strategy for integration of lactate dehydrogenase A suppression into therapeutic algorithms for head and neck cancer.
    Chen Y; Maniakas A; Tan L; Cui M; Le X; Niedzielski JS; Michel KA; Harlan CJ; Lu W; Henderson YC; Mohamed ASR; Lorenzi PL; Putluri N; Bankson JA; Sandulache VC; Lai SY
    Br J Cancer; 2021 May; 124(10):1670-1679. PubMed ID: 33742144
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia.
    Maftouh M; Avan A; Sciarrillo R; Granchi C; Leon LG; Rani R; Funel N; Smid K; Honeywell R; Boggi U; Minutolo F; Peters GJ; Giovannetti E
    Br J Cancer; 2014 Jan; 110(1):172-82. PubMed ID: 24178759
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma.
    Mayr JA; Meierhofer D; Zimmermann F; Feichtinger R; Kögler C; Ratschek M; Schmeller N; Sperl W; Kofler B
    Clin Cancer Res; 2008 Apr; 14(8):2270-5. PubMed ID: 18413815
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lactate dehydrogenase inhibitors can reverse inflammation induced changes in colon cancer cells.
    Manerba M; Di Ianni L; Govoni M; Roberti M; Recanatini M; Di Stefano G
    Eur J Pharm Sci; 2017 Jan; 96():37-44. PubMed ID: 27622920
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lactate dehydrogenase inhibition: exploring possible applications beyond cancer treatment.
    Di Stefano G; Manerba M; Di Ianni L; Fiume L
    Future Med Chem; 2016 Apr; 8(6):713-25. PubMed ID: 27054686
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lactate Dehydrogenase and its clinical significance in pancreatic and thoracic cancers.
    Comandatore A; Franczak M; Smolenski RT; Morelli L; Peters GJ; Giovannetti E
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):93-100. PubMed ID: 36096316
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of lactate dehydrogenase inhibitors on proliferation, motility and invasion of breast cancer cells
    Khajah MA; Khushaish S; Luqmani YA
    Mol Med Rep; 2024 Jan; 29(1):. PubMed ID: 37997856
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibitors of lactate dehydrogenase isoforms and their therapeutic potentials.
    Granchi C; Bertini S; Macchia M; Minutolo F
    Curr Med Chem; 2010; 17(7):672-97. PubMed ID: 20088761
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeting aspartate aminotransferase in breast cancer.
    Thornburg JM; Nelson KK; Clem BF; Lane AN; Arumugam S; Simmons A; Eaton JW; Telang S; Chesney J
    Breast Cancer Res; 2008; 10(5):R84. PubMed ID: 18922152
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autophagy deficiency abolishes liver mitochondrial DNA segregation.
    Tostes K; Dos Santos AC; Alves LO; Bechara LRG; Marascalchi R; Macabelli CH; Grejo MP; Festuccia WT; Gottlieb RA; Ferreira JCB; Chiaratti MR
    Autophagy; 2022 Oct; 18(10):2397-2408. PubMed ID: 35220898
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevated lactate dehydrogenase (LDH) can be a marker of immune suppression in cancer: Interplay between hematologic and solid neoplastic clones and their microenvironments.
    Ding J; Karp JE; Emadi A
    Cancer Biomark; 2017 Jul; 19(4):353-363. PubMed ID: 28582845
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Actual Role of LDH as Tumor Marker, Biochemical and Clinical Aspects.
    Jurisic V; Radenkovic S; Konjevic G
    Adv Exp Med Biol; 2015; 867():115-24. PubMed ID: 26530363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.